nordefrin has been researched along with Cachexia in 1 studies
Nordefrin: A norepinephrine derivative used as a vasoconstrictor agent.
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of COPD improves lung function but is unlikely to slow the steady downhill course of the disease or reduce mortality." | 2.43 | Neurohumoral activation as a link to systemic manifestations of chronic lung disease. ( Andreas, S; Anker, SD; Scanlon, PD; Somers, VK, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreas, S | 1 |
| Anker, SD | 1 |
| Scanlon, PD | 1 |
| Somers, VK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients[NCT03611699] | Phase 4 | 15 participants (Actual) | Interventional | 2019-01-24 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nordefrin and Cachexia
| Article | Year |
|---|---|
Neurohumoral activation as a link to systemic manifestations of chronic lung disease.
Topics: Aldosterone; Animals; Bronchoconstriction; Cachexia; Cardiovascular Diseases; Comorbidity; Heart Rat | 2005 |